ISSN: 1871-529X

Journal Home

Journal Guideline

Cardiovascular and Hematological Disorders - Drug Targets Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cardiovascular and Hematological Disorders - Drug Targets is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 45. It has an SJR impact factor of 0,258 and it has a best quartile of Q3. It has an SJR impact factor of 0,258.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q3) Medicine (miscellaneous) (Q3) Pharmacology (Q3) Hematology (Q4) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cardiovascular and Hematological Disorders - Drug Targets

0,258

SJR Impact factor

45

H Index

31

Total Docs (Last Year)

108

Total Docs (3 years)

1193

Total Refs

98

Total Cites (3 years)

103

Citable Docs (3 years)

0.85

Cites/Doc (2 years)

38.48

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Orthostatic Hypotension: Evaluation and Treatment

Anticoagulant Therapy in Very Old Patients

Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome

Myocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents

Diagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy

Cardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant

EDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History)

Glucose lowering activity of aqueous Ammodaucus leucotrichus extract in diabetic rats

A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress

Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy.

Prevention of Sudden Cardiac Death in Hemodialysis Patients

Rho-Signaling Pathways in Chronic Myelogenous Leukemia

SHOW MORE ARTICLES

Meet Our Editorial Board Member

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Pharmacologic Targeting of Endothelial Progenitor Cells

Pediatric CKD and Cardivascular Disease

Editorial (Thematic Issue:Drug-eluting Stents and Concomitant Treatment)

Effect of a Hybrid Peptide Derived from Platelet Type I and Type III Collagen Receptors on CHO-65 Cells

The Metabolic Syndrome and Vascular Disease in Asia

Author Index To Volume 6

Cardiovascular Effects of Antiretroviral Drugs: Clinical Review

Clopidogrel-Proton Pump Inhibitor Interaction: A Primer for Clinicians

Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature

Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs